Arizona MPJE (Pharmacy Jurisprudence) Practice Exam

The correct response is that a missing CII emergency prescription must be reported to both the Board of Pharmacy and the Drug Enforcement Administration (DEA). When a controlled substance, particularly a Schedule II (CII) drug, is prescribed under emergency conditions, proper tracking and accountability are essential to prevent misuse or diversion.

Reporting to the Board of Pharmacy ensures that state regulations are being followed and provides oversight to maintain the integrity of the pharmacy practice within the state. Meanwhile, the DEA handles federal regulations concerning controlled substances, and it is responsible for the enforcement of laws pertaining to drug trafficking and misuse. Thus, informing both entities allows for a comprehensive response to any potential issues arising from the missing prescription.

Other options, while they may contain entities related to drug regulation and health care, do not encompass the critical oversight roles played by the Board of Pharmacy and the DEA in matters involving controlled substances. The FDA primarily oversees drug safety and efficacy, rather than specific prescriptions or their enforcement. The Pharmacy Economic Council does not have a regulatory function in this context, and while the prescriber may need to be informed about the situation, they are not the regulatory body that governs the reporting of missing prescriptions.